MedPath

Renal Outcome with Empagliflozin in non-diabetic Chronic Kidney Disease Patients: A Randomized Control Trial

Phase 2
Conditions
Chronic kidney disease
Renal and Urogenital - Kidney disease
Registration Number
ACTRN12622000265774
Lead Sponsor
Zara Nisar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
140
Inclusion Criteria

Non-diabetic CKD patients, stage 3&4.
Age greater than or equal to 18 years.
Both male & females

Exclusion Criteria

Major surgery during the last 6 months
Pregnant or nursing mothers
Patients on transplantation list
Patients on dialysis
Patients who are allergic to any drug
Patients with malignancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath